tiprankstipranks
Lipocine (LPCN)
NASDAQ:LPCN
US Market
Holding LPCN?
Track your performance easily

Lipocine (LPCN) Financial Statements

882 Followers

Lipocine Financial Overview

Lipocine's market cap is currently ―. The company's EPS TTM is $-0.759; its P/E ratio is -6.41; Lipocine is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ -1.00$ 89.56K$ 7.62M$ -3.12M$ 10.00
Gross Profit$ -1.00$ 89.56K$ 7.62M$ -3.12M$ 10.00
EBIT$ -2.22M$ -3.07M$ 3.22M$ -6.65M$ -3.55M
EBITDA$ -2.21M$ -2.84M$ 3.23M$ -6.64M$ -3.29M
Net Income Common Stockholders$ -2.22M$ -3.07M$ 3.51M$ -6.65M$ -3.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.82M$ 22.55M$ 24.63M$ 23.85M$ 25.79M
Total Assets$ 20.70M$ 23.03M$ 25.45M$ 24.75M$ 30.48M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -19.82M$ -22.55M$ -24.63M$ -23.85M$ -25.79M
Total Liabilities$ 1.58M$ 1.68M$ 1.43M$ 2.27M$ 1.93M
Stockholders Equity$ 19.12M$ 21.35M$ 24.01M$ 22.48M$ 28.55M
Cash Flow-
Free Cash Flow$ -2.91M$ -2.50M$ 2.41M$ -2.61M$ -3.31M
Operating Cash Flow$ -2.83M$ -2.50M$ 2.41M$ -2.61M$ -3.31M
Investing Cash Flow$ 1.02M$ 4.75M$ -4.09M$ 1.24M$ 3.56M
Financing Cash Flow-$ 217.44K$ -8.10K$ 421.08K$ -5.20K
Currency in USD

Lipocine Earnings and Revenue History

Lipocine Debt to Assets

Lipocine Cash Flow

Lipocine Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis